Nuvation Bio Inc.
NUVB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811063
In the last 90 days, Nuvation Bio Inc. insiders filed 0 open-market purchases and 1 sale; 244 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; 3 superinvestors hold it, including Duquesne Family Office and Abrams Capital.
Holders of 5% or more of NUVB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nuvation Bio Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 15.00%50.6M shares | +1.50 ppfrom 13.50% | Dec 6, 20243 filings | May 12, 2025 | SEC |
| BlackRock, Inc. | 13G | 6.40%21.7M shares | +1.50 ppfrom 4.90% | Apr 28, 20252 filings | Jul 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Nuvation Bio Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G | 6.40%21.7M shares | +1.50 ppfrom 4.90% | Jun 30, 2025 | SEC |
| May 12, 202510:36 AM ET | FMR LLCand 1 other | 13G/A | 15.00%50.6M shares | +1.50 ppfrom 13.50% | Mar 31, 2025 | SEC |
| Apr 28, 20255:58 PM ET | BlackRock, Inc. | 13G/A | 4.90%16.4M shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 12, 20259:30 AM ET | FMR LLCand 1 other | 13G/A | 13.50%45.3M shares | +1.60 ppfrom 11.90% | Dec 31, 2024 | SEC |
| Dec 6, 202411:35 AM ET | FMR LLCand 1 other | 13G/A | 11.90%40.0M shares | – | Nov 29, 2024 | SEC |
| Feb 19, 2021 | Omega Fund V, L.P. | 13DOld format | – | New | – | SEC |
| Feb 19, 2021 | Hung David | 13DOld format | – | New | – | SEC |
| Feb 16, 2021 | Castle Creek Arbitrage, LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Highbridge Capital Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | EcoR1 Panacea Holdings, LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nuvation Bio Inc. shares.
No Form 144 notices for Nuvation Bio Inc. are on file.